Introduction {#S6}
============

Medical imaging is widespread, and its value is firmly established in routine oncologic practice. Image-based biomarkers are used during screening, staging, stratifying, and intervention planning (surgery and radiation therapy) ([@R1]--[@R3]) and for predicting treatment outcomes ([@R4]). In current practice, a radiologist semantically annotates only a small number of radiologic features as having some clinical significance during manual assessment of the images (ie, with the unaided human eye). These few features may include Response Evaluation Criteria in Solid Tumors ([@R5]) and World Health Organization criteria ([@R6]) for treatment response; a change in the mean apparent diffusion coefficient ([@R7]); morphologic descriptors (eg, spiculation) ([@R8]); or the number of voxels exceeding a threshold for selective uptake of a radioactive tracer ([@R9]).

Tumor phenotypes, as they are manifest in medical images, may contain more information than can be readily processed by the unaided human eye. Recent studies have suggested that complex shape metrics and the nonuniform appearance of the tumor mass in images (ie, texture) also provide information about the likely outcome of the disease ([@R3], [@R10]--[@R12]).

Radiomics is the computerized extraction of quantitative features from medical images, beyond the level of detail accessible to an unaided human eye, with the intent to automatically label clinically significant tumor phenotypes ([@R13]). Radiomics entails large-scale batch processing ([@R14]) via high-throughput computational "pipelines" that integrate some or all of the following steps: image pre-processing, tumor segmentation, feature extraction, feature selection, machine learning---based predictive modeling, and model validation ([@R15]).

A systematic review of false discovery rates in textural analysis of medical images ([@R16]) clearly showed that optimal cutoff selection for tuning machine-learning predictive models ([@R17]) in combination with a large number of candidate image features (approximately 100) leads to an increased risk of type I error. Furthermore, related sets of image-derived features tend to be strongly correlated with each other, and this increases the risk of falsely significant associations. There are strong interclass correlations for features derived from similar matrix operations ([@R18]), and there may be correlations to the absolute tumor volume ([@R19]).

There are ways to reduce the risk of a false-positive association. First, only features with high repeatability and high reproducibility should be used for training the predictive models. "Repeatability" refers to features that remain the same when imaged multiple times in the same subject, be that a human person or a suitable phantom ([@R14], [@R20]). "Reproducibility" refers to features that remain the same when imaged using different equipment, different software, different image acquisition settings, or different operators (eg, other clinics), be that in the same subject or in different subjects ([@R14], [@R20]). Second, estimates of predictive performance in single-institution cohorts should include multiple-folded repeated cross validation to minimize the risk of overfitting ([@R21]). Last, assessment of predictive models based on radiomic features should be based on independent external validation in multi-institutional settings ([@R22]).

The purpose of this systematic review was to determine which broadly generic type of radiomic features has been shown to be repeatable and/or reproducible in peer-reviewed studies and, if applicable, what degree of repeatability and reproducibility might be achievable. It was out of the scope of the reviewers performing this study to provide any subjective evaluation concerning the goodness of a study. For example, when evaluating the quality of reporting of a study, we only retrieved objective information from the article, without assigning a score aiming at judging the overall quality of the article.

Methods and Materials {#S7}
=====================

Eligibility criteria {#S8}
--------------------

We conducted this systematic review during March and April 2017. Reporting of this review complies with the PRISMA-P Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement ([@R23]). The included articles met all of the eligibility criteria given in the subsequent paragraphs.

### Report design {#S9}

We included only peer-reviewed full-text reports published in journals that presented full results of repeatability and/or reproducibility tests on radiomic features. With full results, we intend all the articles that matching the inclusion criteria defined in material and methods, presented a statistical analysis of radiomics reproducibility and repeatability. Only articles that included (in their titles or abstracts) at least 1 of the search words specified in the search string were identified.

### Population {#S10}

With regard to the population reported in the study, we included either ([@R1]) studies of human persons diagnosed with 1 (or more) known and clearly stated primary solid tumor where medical imaging in the form of computed tomography (CT), positron emission tomography (PET), and/or magnetic resonance imaging (MRI) was used or ([@R2]) studies consisting of radiologic phantoms where medical imaging in the form of CT, PET, and/or MRI was used. We excluded studies consisting of animal subjects, studies using biological samples taken from the human body, nonclinical imaging studies, or studies in which the type of primary tumor was not objectively known.

### Outcomes {#S11}

The primary criterion for inclusion was an assessment of the repeatability and/or reproducibility of any number of radiomic features with respect to any equipment-, scan-, subject-, or observer-related cause. Included studies also had to report at least 1 of the following quantitative outcomes of interest: variability of radiomic features with respect to image acquisition parameters, imaging modalities examined, or effect of preprocessing steps applied to the images from which features were extracted.

### Language {#S12}

Only full-text reports in the English language were included in this review.

Information sources {#S13}
-------------------

The Cochrane Database of Systematic Reviews was screened for any previous systematic reviews addressing repeatability and/or reproducibility of radiomic features. An electronic search was conducted in PubMed (MEDLINE citations had been previously merged into the PubMed repository). For all articles for which the full text was obtained for data extraction, the bibliographic references within them were also screened for potentially eligible studies. No search was made in gray-literature sources for unpublished material or conference proceedings.

Search strategy {#S14}
---------------

A search of PubMed citations was performed using the broad Haynes ([@R24]) and Ingui ([@R25]) filters in combination with the modifications proposed by Geersing et al ([@R26]) (each combined using "OR"). For the final database search, additional criteria of "cancer" (Medical Subject Headings major topic) and text terms that were each related to reproducibility, repeatability (fundamental to include test-retest studies), variability, and radiomics (including textural analyses) were also included. All PubMed search results were admitted up to and including the second week of April 2017.

Study records {#S15}
-------------

### Data management {#S16}

Electronic full-text articles were downloaded using university library subscriptions. A review-specific SharePoint (Microsoft Corporation, USA) page was set up to handle document collection, data extraction forms, and dissemination of reviewer findings.

### Selection process {#S17}

Two reviewers worked independently throughout all phases of the study selection process (abstract screening, eligibility, and inclusion for full-text evaluation). They compared the titles and abstracts against the inclusion criteria. Each reported whether an abstract was eligible for evaluation in full. Disagreements were resolved by consensus. All of the articles deemed eligible were successfully downloaded.

Two reviewers independently evaluated whether the full-text reports were suitable for inclusion and synthesis. Dis-agreements were again resolved by consensus. A third reviewer was available if disagreements could not be resolved, but this option was not exercised. Reasons for excluding a specific full-text article were documented.

Data extraction: data items {#S18}
---------------------------

We extracted information about the population used in the studies, including the sample size and type of primary tumor for human studies and the phantom details for phantom studies. The inclusion of metastatic, secondary, or synchronous tumors was noted, as was any case in which the nonprimary tumor was used in the derivation of radiomic features. The study design and image modality used were noted, including any image acquisition parameters explicitly stated in the text. We noted the total number of radiomic features tested and grouped these features according to ([@R1]) shape features (defining the 2-dimensional or 3-dimensional \[3D\] properties of the tumor, eg, volume or surface area); ([@R2]) first-order statistics (derived from statistical moments of the image intensity histogram); and ([@R3]) higher-order textural features (describing spatial patterns of voxel intensities) ([@R27]).

In addition, we noted the names and versions of the software used to quantitatively extract radiomic features, including whether any particular preprocessing steps were applied to the images before feature extraction. Finally, we noted the statistical methods used as a metric of repeatability and/or reproducibility of the studied features.

Outcomes and prioritizations {#S19}
----------------------------

### Primary outcome {#S20}

The primary outcome of interest in this review synthesis was the degree of repeatability or reproducibility of radiomic features, along with any independent validation used to test repeatability and reproducibility at an external institution.

### Secondary outcomes {#S21}

The secondary outcomes were the impact of image acquisition settings on the reproducibly of features and the effect of preprocessing imaging filters applied before feature extraction.

### Additional outcomes {#S22}

Additional outcomes were the statistics and metrics used for reporting robustness and reliability and the investigation of the impact of different segmentation methods used to define the regions of interest (ROIs).

### Risk of bias in individual studies {#S23}

To assess the risk of bias in each study, 2 reviewers independently extracted detailed information from the reports in the following specific domains:

1.  Characteristics of the cohort used to perform the study in the case of human studies or characteristics of the phantom used to perform the study in the case of phantom studies

2.  Description of the software used to compute the features

3.  Image acquisition parameters reported in the study

4.  Filtering and/or image preprocessing operation(s) performed on the original scan before the radiomic features underwent computation

5.  Segmentation method(s) used to derive an ROI

6.  Use of either cross validation or independent validation to show that features are repeatable and/or reproducible after folding or in separate data sets

7.  Threshold (cutoff) values used in repeatability and/or reproducibility metric(s) to segregate features

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis classifications were not applicable here because tests of repeatability and reproducibility of radiomic features do not strictly link to diagnostic verification or predictive performance. The impact of undocumented (or inadequately reported) steps on the potential repeatability or reproducibility of features was noted. Discrepancies in data extraction between the 2 reviewers were resolved by consensus after discussion. A third reviewer was available to resolve a deadlock, but this option was not needed.

### Data synthesis {#S24}

The included studies were not uniform by way of reported metrics, and we could not attempt a quantitative meta-analysis of pooled metrics. A systematic qualitative synthesis is given in this publication, with details presented in text and tables to summarize our findings about the included studies.

### Subgroup analyses {#S25}

The summary findings on repeatability and reproducibility of features were grouped by the following: disease type (lung cancer, head and neck cancer, and other anatomic sites) or phantom study and type of imaging modality (CT, PET, and MRI).

Results {#S26}
=======

Literature search results {#S27}
-------------------------

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram is shown in [Fig. 1](#F1){ref-type="fig"}. The PubMed search yielded 624 abstracts for screening against our selection criteria, reduced to 623 after elimination of duplicates. The full text was retrieved for 52 abstracts deemed suitable for in-depth evaluation, including 5 that were located in the references of retrieved studies and 2 previously known studies. After full-text evaluation, 11 studies were excluded because they did not meet the aforementioned eligibility criteria. A qualitative synthesis was derived from 41 studies, of which 35 were performed in human subjects and 6 were exclusively performed on radiologic phantoms. A detailed checklist is provided in [Appendix E1](#SD1){ref-type="supplementary-material"} (available online at <https://doi.org/10.1016/j.ijrobp.2018.05.053>).

Human study characteristics {#S28}
---------------------------

[Table 1](#T1){ref-type="table"} summarizes the general characteristics of the human studies. The vast majority of studies addressed lung cancer (25 of 35 studies), of which 21 specifically addressed non-small cell lung cancer (NSCLC). There were 3 studies each on head and neck cancer, esophageal cancer, and rectal cancer. There was only 1 study each on breast cancer and cervical cancer. In 2 studies, multiple cancer types were combined, but details within the subgroups of cancer types were not specified ([@R59], [@R60]). Two studies combined features from multiple specified cancers ([@R19], [@R57]).

The number of patients reported in the retrieved studies ranged from 10 ([@R33]) to 555 ([@R54]), and only 1 study was prospective ([@R56]). Few studies (7 of 41) specifically referred to a publicly available image set.

The imaging modalities mentioned in the human lung studies were PET (17 of 35), CT (17 of 35), MRI (1 of 35), and cone beam CT (CBCT) (2 of 35). Two studies used multiple imaging modalities. Six studies exclusively investigated feature repeatability; all others examined either reproducibility alone or both reproducibility and repeatability.

The number of investigated radiomic features in the studies ranged from 4 ([@R45]) to 830 ([@R38]). The latter was a multi-institutional study, so it was unclear whether the number included repeated instances of some of the features. All the studies included textural analysis; the majority (28 of 35) also evaluated first-order features, but less than half (15 of 35) evaluated shape metrics. Fourteen studies investigated all categories of features.

Phantom study characteristics {#S29}
-----------------------------

[Table 2](#T2){ref-type="table"} shows the main characteristics of 6 studies exclusively concerning radiologic phantoms. Among these, CT was the most common image modality (5 of 6), and PET was investigated in only 1 study. We did not locate any phantom study of repeatable and/or reproducible features from MRI. All of these studies investigated feature reproducibility, and only 1 phantom study was prospective ([@R65]).

The number of investigated radiomic features in the phantom studies ranged from 5 ([@R63]) to 213 ([@R65]). All studies included textural analysis, 3 evaluated first-order features, and 2 evaluated shape metrics. Only 1 study investigated all categories of features ([@R65]).

Quality of reporting in included studies {#S30}
----------------------------------------

### Human studies {#S31}

[Table 3](#T3){ref-type="table"} gives a summary of methodology and reporting quality for human studies. In general, methodologic aspects were adequately documented. However, only 7 of 35 studies reported detailed information in every one of the aforementioned quality domains ([@R28], [@R33], [@R42], [@R51]--[@R53], [@R56]). In 3 quality aspects, the overall standard of reporting was lower: ([@R1]) providing details of the software implementation to extract radiomic features, ([@R2]) providing details pertaining to image preprocessing before extracting radiomic features, and ([@R3]) stating the cutoff value for discriminating a subset of repeatable and/or reproducible features.

One study did not provide detailed information about the disease groups used in the analysis, apart from stating that different types of solid cancers were included ([@R59]). The practice of pooling heterogeneous tumors is questionable because there is no a priori reason to assume that any arbitrary feature that may be stable in one disease site will also prove to be stable in others.

Software details (application framework used for analysis, programming language, and version) were not reported in detail in 16 studies. Standards for radiomic features have not yet been universally adopted; therefore, software should be described because differences due to feature extraction are likely to influence the apparent stability of features.

All but 2 studies ([@R31], [@R32]) provided detailed tables describing image acquisition settings including information about scanners (manufacturer, model, reconstruction package, and software version) and scan protocols. Eight studies lacked detailed descriptions regarding preprocessing steps (if any) applied to the original images ([@R4], [@R29], [@R37]--[@R39], [@R41], [@R46]). Digital image manipulations (eg, voxel size resampling, de-noising, and sharpening) are known to drastically alter the extracted values, and this is likely to hamper reproducibility across data sets.

Six studies did not provide sufficient information regarding the segmentation procedures to define an ROI ([@R32], [@R35], [@R37], [@R40], [@R45], [@R57]). Differences in segmentation methods are likely to bias the stability of shape metrics and perhaps textural and first-order features.

Fifteen studies did not document the cutoff value used in their statistical metrics to discriminate between reproducible and irreproducible features. One of these selected only the top-ranking feature from each of 4 feature groups (first order, shape metric, texture, and wavelet filtered) ([@R4]). The subset of stable radiomic features selected in a given study obviously depends on arbitrary threshold values of the repeatability or reproducibility metric; therefore, the cutoff criterion should be clearly stated.

Two studies validated feature stability in texture phantoms combined with publicly available clinical images ([@R33], [@R40]). One study assessed feature reproducibility across 7 institutions ([@R38]).

Seven studies made their primary data set of clinical images publicly available to other researchers ([@R4], [@R28], [@R30], [@R32], [@R37], [@R38], [@R42]), and some of these studies used the same publicly available data set.

### Phantom studies {#S32}

[Table 4](#T4){ref-type="table"} provides an overview of methodologic aspects and reporting quality for the phantom studies. All studies reported information about the phantom used in the analysis. All provided detailed tables describing image acquisition settings, including information about scanners (manufacturer, model, reconstruction package, and software version) and scan protocols. However, no studies reported detailed information in every one of the aforementioned quality domains. In 2 quality aspects, the overall standard of reporting was lower: ([@R1]) providing details of the software implementation to extract radiomic features and ([@R2]) stating the cutoff value for discriminating within a subset of reproducible features.

Four studies made use of commercially available phantoms originally designed for scanner calibration or image quality checks, whereas 2 studies used an in-house texture phantom ([@R61], [@R65]). Software details (application framework used for analysis, programming language, and version) were not reported in the majority of studies. Five studies described their in-house software as based on MATLAB (The MathWorks) ([@R61], [@R62], [@R64]--[@R66]), and Kim et al ([@R63]) developed a plug-in for the open-source software ImageJ (National Institutes of Health), but none of these studies made their code accessible.

Only Forgacs et al ([@R62]) lacked a detailed description regarding preprocessing steps (if any) that were applied to the original images. One study did not provide sufficient information regarding the segmentation procedures to define an ROI ([@R62]). Three studies relied on manual segmentations ([@R61], [@R63], [@R65]), and the remainder used semi-automated segmentations while also specifying the algorithms used.

Five studies did not document the cutoff values used in their statistical metrics to discriminate between reproducible and irreproducible features ([@R61], [@R63], [@R64], [@R65], [@R66]). The statistical analysis was unclear in the text in the study by Kim et al ([@R63]).

Radiomic features according to cancer diagnosis {#S33}
-----------------------------------------------

### Lung cancers {#S34}

The imaging modalities among lung cancer studies were CT (14 studies), PET (11 studies), and CBCT (1 study). Desseroit et al ([@R31]) investigated PET and CT at the same time. All of the studies investigating PET acquired these images using a combined PET-CT scanner. Twenty-one studies used NSCLC data sets, and 4 studies used a combination of different lung cancers ([@R47]--[@R49], [@R57]).

Three studies evaluated the reproducibility of radiomic features with respect to multiple manual segmentations in the same patient (interobserver sensitivity) by use of PET ([@R4], [@R39], [@R43]). Each showed that interobserver differences in delineations affected feature reproducibility to some degree. Interobserver differences were amplified in textural features. Leijenaar et al ([@R39]) found that features with high test-retest repeatability were also less affected by interobserver differences. Parmar et al ([@R42]) studied interobserver variability with respect to manual versus semiautomated segmentation (3D Slicer) and concluded that semiautomated methods improved feature reproducibility in PET. Orlhac et al ([@R19]) studied textural feature reproducibility with respect to 2 different semiautomated segmentation algorithms: an adaptive method ([@R67]) and a more conventional thresholding method based on 40% of the maximum standardized uptake value. Homogeneity, contrast, dissimilarity, and coarseness were found to be the most reproducible features.

The only multicenter CT study found that among shape metrics, 3 variants---local shape descriptors, global shape descriptors, and textural features---had the highest variation with respect to segmentations, whereas size measures had the least variation resulting from segmentation ([@R38]). First-order features were highly reproducible across participating centers, and there were strong internal correlations within each class of features.

Four studies examined the impact of different PET image reconstruction algorithms or image processing filters ([@R19], [@R43], [@R44], [@R49]). Grid size had a larger impact on feature reproducibility than did simple Gaussian filters applied inside the image reconstruction algorithms; the latter affected reproducibility in only shape and textural features. Gray-level resampling sensitively affects textural feature reproducibility, whereas first-order features are less affected. Differences in reconstruction algorithms strongly affect feature reproducibility, with the exception of first-order entropy. Entropy was reproducible for both image preprocessing and several reconstruction algorithms.

Three studies compared features using free-breathing PET versus respiratory-gated PET to evaluate the impact of motion on reproducibility but showed conflicting results. In the study by Oliver et al ([@R41]), spatial blurring effects due to respiratory motion and intrinsic noise during acquisition were major factors leading to irreproducibility. Similar results were seen when textural features on 3D versus 4-dimensional (4D) PET were compared ([@R45]). The latter study concluded that 4D imaging reduced motion artifacts, producing less blurred images and potentially more reproducible textural features. However, in the study by Grootjans et al ([@R47]), the differences between features derived from 3D and 4D imaging were not statistically significant.

Zhao et al ([@R46]) evaluated the combined effect of 3 different CT slice thicknesses and 2 different CT reconstruction algorithms. Many features that had been repeatable under test-retest conditions became irreproducible with respect to altered slice thickness and image reconstruction settings, with first-order features and shape metrics being less sensitive than textural features.

Fave et al ([@R35]) tested the effect of different image preprocessing filters, such as bit-depth resampling and smoothing filters, on CT radiomic features. Correlation to tumor volume and use of preprocessing filters increased the chance of features being significant on univariate analysis against outcome, but whether these retain their predictive value in an independent validation set remains unclear.

Three studies focused exclusively on repeatability using the same test-retest images ([@R31], [@R37], [@R57]). They consistently found shape metrics and first-order features to be highly repeatable, but there was no consensus on repeatable textural features.

Two studies investigated feature reproducibility across different scanning equipment using a specially constructed texture phantom: Fave et al ([@R33]) using CBCT and Mackin et al ([@R40]) using CT. Both investigations went on to validate their phantom results using clinical images. Feature reproducibility using CBCT was adversely affected by motion and scattered radiation, whereas interscanner CT differences were found to be of the same magnitude as interpatient feature differences.

### Head and neck cancers {#S35}

Three studies were concerned with head and neck cancers; all primary tumors were located in the oropharynx. Modalities investigated were CT ([@R51]), CT and CBCT ([@R50]), and PET ([@R52]). Each of these investigated some aspect of image resampling filters or other preprocessing regarding feature reproducibility.

Bagher-Ebadian et al ([@R50]) applied different smoothing, sharpening, and noise filters to CBCT and CT images and found that feature reproducibility in both modalities was most strongly affected by high-pass filters and logarithmic filters. Smoothing filters and Gaussian noise kernels had a similar but smaller impact on reproducibility. The authors found no major differences in reproducibility between CT and CBCT.

The effect of gray-level discretization was discussed in 2 studies: those by Bogowicz et al ([@R51]) using CT and Lu et al ([@R52]) using PET. The first found that bin size strongly affected reproducibility on perfusion CT, but the second found a qualitatively similar though less severe impact on reproducibility in PET.

Lu et al ([@R52]) also compared different PET segmentation methods (manual, semiautomated, and fully automated) and found that more than half of the radiomic features were reproducible. In addition, the sensitivity of features due to segmentation differences was less than that due to voxel dimension resampling.

### Esophageal cancers {#S36}

Three studies were concerned with esophageal cancer. All 3 investigated PET modalities. Tixier et al ([@R55]) investigated the effect of different PET reconstruction algorithms in esophageal cancer. The most reproducible tumor heterogeneity markers were entropy, homogeneity, and dissimilarity (for local characterization) and variability in the size and intensity of homogeneous tumor regions (for regional characterization). The other 2 studies investigated how different thresholding-based semiautomated segmentation algorithms affect feature reproducibility. The impact was less marked with first-order features than with textural features. Entropy was the most reproducible first-order feature, and homogeneity was the most reproducible textural feature. Segmentation affected reproducibility more than either smoothing or filtering.

### Rectal cancers {#S37}

Three studies were concerned with rectal cancers. Modalities investigated included CT (2 studies) and PET (1 study). Orlhac et al ([@R19]) studied textural feature reproducibility using PET with respect to different segmentation algorithms and gray-level resampling. Only a few features (homogeneity, contrast, dissimilarity, and coarseness) were found to be highly reproducible with respect to segmentation and resampling. Two studies investigated feature repeatability using CT ([@R56], [@R57]). Shape features were again found to be the most repeatable, and higher-order textural features were the least reproducible. Normalizing the extracted values by ROI volume generally improved the overall repeatability of features.

### Other cancers {#S38}

Studies were limited for other cancers. Guan et al ([@R58]) investigated feature reproducibility in the apparent diffusion coefficient from MRI of cervical cancer with respect to interobserver and intraobserver variability. All entropy measures were highly reproducible independent of observer effects. Orlhac et al ([@R19]) investigated textural feature reproducibility using PET in breast cancer. Only a few features (contrast, coarseness, and high gray-level run emphasis) were reproducible with respect to the number of gray levels used for resampling.

Radiomic features according to imaging modality {#S39}
-----------------------------------------------

### Positron emission tomography {#S40}

PET was the second most common imaging modality overall and the most common in lung cancer. First-order statistics derived from a standard uptake value (SUV) histogram, such as mean SUV and maximum SUV, were consistently among the most repeatable and reproducible. Interclass correlation coefficients of these features were consistently higher than 0.95. First-order PET features were generally robust with respect to segmentation, but textural features consistently showed greater sensitivity to segmentation differences ([@R4], [@R19], [@R39], [@R42], [@R43], [@R53]). The choice of image reconstruction algorithm had a greater effect on reproducibility of shape metrics and textural features relative to first-order features ([@R43], [@R44], [@R49]).

### Computed tomography {#S41}

Studies using CT were most common in head and neck cancer (2 studies) ([@R50], [@R51]), and CT was the second most common modality in lung cancer (14 studies). First-order and shape CT features were generally more repeatable than textural features ([@R32], [@R56], [@R57]). Slice thickness resampling and different reconstruction algorithms strongly degraded feature reproducibility ([@R35], [@R46], [@R50], [@R51]). The magnitude of degradation was greater for textural features than for first-order features.

### Cone beam CT {#S42}

CBCT was used in 1 NSCLC study ([@R33]) and 1 oropharyngeal cancer study ([@R50]). Radiomic feature reproducibility on CBCT appeared to be adversely affected by scattered X rays and specifics of the imaging device. Low-amplitude noise and smoothing did not appear to affect the correlation of CBCT features to planning CT.

Radiomic features according to phantom studies {#S43}
----------------------------------------------

All the studies that investigated reproducibility on CT agreed that voxel size resampling strongly affected feature reproducibility. Zhao et al ([@R66]) demonstrated substantial differences in reproducibility when comparing 1.25- and 5-mm slices. Volume, homogeneity, and energy (gray-level co-occurrence matrix) were more reproducible for the finer slice thickness. This study recommended using images with a slice thickness between 1 and 2.5 mm for radiomic analysis. Studies confirmed that other CT acquisition parameters, such as tube voltage or tube current, had no influence on feature reproducibility ([@R61], [@R62]).

Predictive or prognostic power of reproducible or repeatable features {#S44}
---------------------------------------------------------------------

Of the 35 articles investigating feature reproducibility and repeatability in human studies, only 11 also addressed the prognostic or predictive value of computed features ([Table E1](#SD2){ref-type="supplementary-material"}, available online at <https://doi.org/10.1016/jAjrobp.2018.05.053>). Ten studies used NSCLC data sets, and only 1 study was based on esophageal cancers. Five studies investigated clinical outcome and patients' overall survival, 2 investigated the role of features in stratifying patients according to poor or good prognosis (based on mean overall survival), 3 investigated the pathologic response to treatment, and 1 investigated tumor recurrence. All studies agreed that models including quantitative imaging features have better performance than models including only clinical features. The majority of the studies found textural analysis features to be predictive or prognostic. Unfortunately, there is no consensus on most predictive textural analysis features. In addition, some studies found some first-order features to be predictive, but unfortunately, it was not possible to find a consensus. We suggest that authors clearly document the procedure adopted for feature selection for their models, possibly by making use of workflow figures.

Methodologic issues identified in review {#S45}
----------------------------------------

### Accessibility of software for feature extraction and of image collections {#S46}

The included studies used a wide range of software to process images and extract features. Fourteen studies specifically identified MATLAB as the framework for their feature extraction algorithms ([@R4], [@R28], [@R29], [@R36], [@R37], [@R39], [@R42], [@R45], [@R50], [@R52], [@R53], [@R56], [@R59], [@R61]). Software in the studies by Bogowicz et al ([@R51]) and Kim et al ([@R63]) were based on in-house code written for Python and ImageJ, respectively. Twenty studies did not report any details about the software used. Only 1 of the aforementioned studies has made its source code available in a GitHub repository ([@R52]).

Among MATLAB users, only Aerts et al ([@R4]) and Balagurunathan et al ([@R28]) have made their image sets publicly accessible online. Kalpathy-Cramer et al ([@R38]) and Oliver et al ([@R41]) also used in-house created software, but neither provided additional details or made the software publicly accessible. Kalpathy-Cramer et al ([@R38]) provided open access to images and structure sets (for 40 patients and 1 phantom) via The Cancer Imaging Archive (TCIA). Four studies used the IBEX open-source radiomics package ([@R68]), developed by MD Anderson Cancer Center, but their image collections are not publicly accessible online ([@R33], [@R34], [@R35], [@R40]).

Among phantom studies, only 2 reported the software used to extract radiomic features. Buch et al ([@R61]) used MATLAB as the framework application for their feature extraction algorithms, and Kim et al ([@R63]) developed a dedicated plug-in for ImageJ. However, none of the phantom studies had publicly released their image sets.

It would be difficult to compare, for consistency and standardization, the radiomic features extracted by different software implementations if values for a canonical set of features were not openly accessible. Furthermore, feature stability and predictive performance of radiomic features cannot easily be externally validated unless other researchers have access to either the extraction software or the medical images (or both).

### Heterogeneity in statistical metric and cutoff values {#S47}

The human subject studies in this synthesis were highly heterogeneous regarding statistical metrics for repeatability and/ or reproducibility. The metrics encountered were the intra-class correlation coefficient (ICC) in 14 studies, concordance correlation coefficient (CCC) in 7 studies, Spearman rank correlation in 5 studies, and various descriptive measures of difference among the remaining 9 studies. Some studies reported more than a single metric. However, the specific cutoff values used to segregate stable from unstable features were not always stated. When stated, the threshold values were highly study dependent. This led to differences in the individual features that were deemed repeatable or reproducible, and there was no universal consensus.

The ICC metric ([@R69]) is appropriate where one expects strong correlation within a given class but weak correlation between classes, and it was most commonly reported in reproducibility experiments. Five of these ICC-based studies failed to report the threshold value used to consider a feature as reproducible. The others defined a feature as highly reproducible if ICC was \>0.9 ([@R30], [@R43], [@R51]); if ICC was \>0.81 ([@R58]); if ICC was \>0.8 ([@R37], [@R39]); and finally, if ICC was ≥0.8 ([@R42], [@R52]).

The CCC metric ([@R70]) assumed each observation was independent and was commonly reported in both repeatability and reproducibility studies. In the studies by Kalpathy-Cramer et al ([@R38]) and Zhao et al ([@R46]), the cutoff was set at CCC ≥0.75. Other reported cutoffs were CCC ≥0.8 ([@R33], [@R56]), CCC \>0.85 ([@R57]), and CCC \>0.9 ([@R28], [@R36]). Spearman rank correlation ([@R71]) measures the ordinal correlation between features in 2 experiments and was reported in 5 studies.

Human studies also tended to stratify features into ordinal groups (eg, poor, medium, or high reproducibility or repeatability) according to the statistical metric. No study made available its calculated metrics at the level of the individual feature. We did not attempt a meta-analysis of summary statistics in this review.

The phantom studies also used diverging statistical metrics. In the study by Kim et al ([@R63]), the metric was ambiguous. Two studies used the coefficient of variation ([@R62], [@R65]); one study used the mean standard deviation ([@R64]); one study used a multilinear regression method ([@R66]); and Buch et al ([@R61]) used a *t* test. Only Forgacs et al ([@R62]) reported the cutoff used to select reproducible features. For phantom studies, lack of consensus also excluded quantitative meta-analysis of the results.

### Reporting of digital image manipulations before feature extraction {#S48}

Radiomic feature values appeared to be sensitive to preprocessing filters applied to the original image. There was some consensus that first-order features were not as sensitive to image preprocessing as were textural features. Because the latter class of features is highly sensitive to perturbations in local intensity distribution and short-range correlations, the use of prefilters might have enhanced certain details and eliminated information from others.

However, the aforementioned preprocessing steps (if any) were embedded within each software implementation and were seldom explicitly documented. Discrepancies between studies using the same image modalities and the same software may be partly due to undocumented differences in preprocessing, but it would be impossible to rule out differences resulting from image reconstruction algorithm or image acquisition settings.

Qualitative synthesis {#S49}
---------------------

Lung studies generally agreed that ROI segmentation affects the reproducibility of radiomic features for both PET and CT modalities, especially among the shape metrics and textural features. Image reconstruction algorithms revealed a difference between filtration and voxel sampling. The former had more impact on reproducibility of textural features, but the latter reduced the reproducibility of all features. Respiratory motion appears to have had a significant adverse impact on reproducibility of PET and CBCT features. Feature values were correlated to ROI volume in some software implementations, which may lead to a confounding association with certain outcomes.

In general, the head and neck cancer studies agreed that either modifying voxel size or applying intensity discretization influenced feature reproducibility for both CT and PET, but PET seemed overall less sensitive with respect to differences in segmentation. This review did not find any studies addressing differences in image acquisition settings, reconstruction algorithms, or scanners for head and neck cancers.

In PET human subject studies, first-order entropy was one of the most stable features across multiple settings. There were mixed findings for reproducibility of skewness and kurtosis. Shape metrics were also reproducible using PET but were less reproducible using CT, likely because of the manual delineation sensitivity of the latter. Coarseness and contrast appeared to be least stable among the textural features. There was no overall pattern for stable textural features, nor were any significant differences noted due to different isotopes ([@R52]) (ie, ^18^F and ^11^C).

First-order entropy emerged as among the most consistently reproducible features on CT for both oropharyngeal and lung cancers. Single-institution studies concluded that CT shape metrics were highly reproducible, but the only multi-institutional study concluded that shape descriptors (ie, flatness and sphericity) and textural features were the least reproducible ([@R38]). Kalpathy-Cramer et al ([@R38]) also showed that first-order CT features were highly reproducible across participating centers, even for skewness and kurtosis. There was consensus that certain texture features, such as coarseness and contrast, were poorly reproducible. No emergent pattern regarding reproducible PET texture features was found.

No overall trend emerged regarding repeatable and reproducible CBCT textural features. Among first-order features, entropy was one of the most stable features, whereas kurtosis was the least stable.

In general, all phantom studies on CT consistently reported that first-order features such as histogram mean and entropy were the most reproducible features. Similar results for entropy were observed on PET radiomic analysis ([@R62]) when examining reproducibility with respect to different acquisition time intervals and reconstruction settings. The aforementioned qualitative synthesis across all included studies has been summarized in [Fig. 2](#F2){ref-type="fig"}, indicating which process steps are most likely, probable, or least likely to affect the repeatability and reproducibility of radiomic features.

Discussion {#S50}
==========

The total number of published predictive modeling studies using image-based quantitative features has been rapidly rising, but global consensus about features that are repeatable and reproducible has not yet emerged. Lack of unified synthesis could potentially undermine future discussions about clinical applicability and prospective multi-institutional external-validation trials. The primary objective of this review was to identify radiomic features that were shown to be repeatable and reproducible through an electronic search of peer-reviewed journal publications. We also evaluated the methodologic details provided in each of the studies. Summaries of our findings have been presented in tables.

We located a number of general reviews focusing on the process and challenges of radiomic studies ([@R15], [@R72]). The previous work has drawn particular attention to the lack of standardization ([@R73]) and need for calibration of imaging settings. At the time of this writing, there has been no systematic review focusing on repeatability and/or reproducibility studies of radiomic features.

General recommendations for radiomic research {#S51}
---------------------------------------------

To homogenize radiomic reproducibility and repeatability studies, we suggest that the community perform bench-marking studies on common, shared, and publicly available data sets. In particular, this concept has already been proposed within the Image Biomarker Standardization Initiative, where different institutions computed features on a common data set. However, to expand this effort, we have been working on ([@R1]) providing users with a common repository with shared data sets for feature benchmarking; ([@R2]) providing a computational infrastructure, which directly connects to the repository; and ([@R3]) suggesting a standardized way of reporting and collecting computational results.

With regard to point 1, we believe that common data sets should include both phantom and human studies. Because features could be dependent on several acquisition parameters (eg, slice thicknesses and different scanning protocols and/or scanner manufacturers), our recommendations are as follows:

1.  Include benchmarking data sets collected by different institutions to guarantee the maximum heterogeneity in terms of the aforementioned parameters.

2.  Include different data sets for most common modalities and diseases because, as we have shown in the review, feature reproducibility results can be different when considering different diseases and/or different modalities.

With regard to point 2, we are currently working on developing an infrastructure, based on workflow programming language, that allows users to connect to the mentioned repository and run their feature extraction software. This infrastructure can be expanded by introducing in the workflow a "benchmarking module," where users can easily "test" their software on common data sets, directly choosing them according to the modality and/or disease population of interest. In such a module, computational results can then automatically be uploaded, and a "sanity" report of feature reproducibility, compared with values already obtained by other institutions (bench-marking), is returned to the user. We believe that such an infrastructure not only will stimulate users to perform benchmarking calculations but also will help them in terms of debugging their software in case of possible errors.

Point 3 is strictly related to point 2. In fact, bench-marking intrinsically brings the concept of comparisons. For this reason, a standardized way of reporting should be preferred. As already pointed out in this article, users should report not only the obtained features' raw values but also the configurations and/or parameters used to perform computations, together with details of the software used for computations. To facilitate this process, we are working on providing users with standard template tables that need to be filled in by the users and that include all the information mentioned earlier. In our view, this represents the first step toward homogenizing and increasing the quality of reporting. However, to facilitate feature comparison, we recommend using ontology techniques combined with Semantic Web to transform template tables into semantically linked data that can easily be queried by means of universal concepts defined by the ontology.

Finally, to increase the general validity of a radiomics-based model, we believe that external validation of the developed model should be performed, and only reproducible and repeatable features should be included in the model. To achieve this goal, we suggest using a distributed learning approach. In fact, in a distributed learning environment, models are "learned" and validated in different centers to increase their general validity. In addition, we recommend that authors describe in detail the procedure adopted for selecting features in the model. We suggest the following possible workflow:

1.  Perform a reproducibility experiment and rank features from most reproducible to least reproducible.

2.  Start scanning the list, picking up the most reproducible features; train the model; and validate the model externally to investigate the predictive or prognostic power of the features.

As a final point, we recognize the need to create a community of radiomics users, sharing common methodology in terms of both feature computation and methodology. In addition, we believe that this community should be guided by findable, accessible, interoperable, and reusable (FAIR) principles for a standardized, reliable, and reproducible use of radiomics.

Limitations of review {#S52}
---------------------

We are not able to rule out possible publication bias toward favorable results among the included studies. We did not generate a funnel plot because of the relatively low number of eligible studies and because of the specific exclusion of unpublished reports and conference proceedings. Every published study included in our review identified at least 1 radiomic feature that was repeatable or reproducible.

This systematic review was limited to only 2 reviewers; though a third reviewer was available to resolve disagreements, this option was not exercised. No disagreements were found after discussion, when comparing the results of the quality of reporting and the qualitative synthesis.

Furthermore, our search was limited to only 1 literature repository (PubMed) after its incorporation of MEDLINE and Embase citations. We did not permit conference proceedings, non---peer-reviewed publications, or other sources of gray literature in this review, which may have limited the number of studies located.

As a fundamental final point, this review would have benefited from a quantitative synthesis of the analyzed articles. Unfortunately, as already mentioned, the reviewed studies applied arbitrary cutoffs during the statistical analysis of reproducible and repeatable features; in some cases, as we documented in our article, thresholds used to define a feature as "reproducible" were not reported. We have performed the analysis that was amenable to us at this time. However, we strongly support consensus toward a standardized metric to quantitatively evaluate reporting of radiomic studies that will be useful for the community. No such consensus presently exists, and our review was the first attempt to describe what has been reported in the reviewed literature. We did not specifically propose a metric to evaluate the quality of reporting because this needs to be a consensus effort by our community. This can be seen as one of our studys limitations.

An anticipated update of the current review is proposed for April 2019. We hope by that date to have agreed on a common quantitative evaluation metric within the research community so that we will be able to update the review, in terms of not only up-to-date publications but also the inclusion of a quantitative analysis.

Supplementary Material {#SM1}
======================

Supplementary material for this article can be found at <https://doi.org/10.1016/j.ijrobp.2018.05.053>.

Conflict of interest: none.

![Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. The primary PubMed search returned 624 records. A further 5 records were added from references in full-text articles. Two records were added owing to prior knowledge. After screening and full-text assessment, a total of 41 studies were included in the qualitative synthesis.](nihms-1032249-f0001){#F1}

![Qualitative synthesis of radiomic feature classes, indicating processing steps that are either highly likely (3 diamonds), probable (2 diamonds), or less likely (1 diamond) to exert an adverse effect on repeatability and reproducibility for each class of radiomic features. Feature classes for which no information was available are marked as unknown (question mark). *Abbreviations:* CBCT = cone beam computed tomography; CT = computed tomography; H&N = head and neck cancer; NSCLC = non-small cell lung cancer; PET = positron emission tomography; ROI = region of interest.](nihms-1032249-f0002){#F2}

###### 

Summary of human studies included in analysis

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                              Disease                               Modality\      No. of\      Primary\    Total\     Class of\    Statistical\                      Type of\
                                                                               investigated   patients     set made\   NO. Of\    features     analysis                          study
                                                                                                           public      features                                                  
  -------------------------------------- ------------------------------------- -------------- ------------ ----------- ---------- ------------ --------------------------------- --------------------------------
  Aerts et al ([@R4]), 2014              NSCLC                                 CT             52           Yes         440        FO, SM, TA   ICC                               Repeatability, reproducibility

  Balagurunathan et al ([@R28]), 2014    NSCLC                                 CT             32           Yes         330        FO, SM, TA   CCC                               Reproducibility

  Cheng et al ([@R29]), 2016             NSCLC                                 PET            56           No          12         TA           ICC                               Reproducibility

  Coroller et al ([@R30]), 2016          NSCLC                                 CT             32           Yes         1603       FO, SM, TA   ICC                               Repeatability

  Desseroit et al ([@R31]), 2017         NSCLC                                 PET, CT        73           No          49         FO, TA       ICC                               Repeatability

  Desseroit et al ([@R32]), 2016         NSCLC                                 CT             32           Yes         34         FO, SM, TA   Mean standard deviation           Repeatability

  Fave et al ([@R33]), 2015              NSCLC                                 CBCT           10           No          68         FO, TA       CCC                               Reproducibility

  Fave et al ([@R34]), 2015              NSCLC                                 CT             40           No          20         FO, SM, TA   Spearman correlation              Reproducibility

  Fave et al ([@R35]), 2016              NSCLC                                 CT             134          No          55         FO, TA       Spearman correlation              Reproducibility

  Fried et al ([@R36]), 2014             NSCLC                                 CT             91           No          30         FO, TA       CCC                               Reproducibility

  Huynh et al ([@R37]), 2017             NSCLC                                 CT             32           Yes         644        FO, SM, TA   ICC                               Repeatability

  Kalpathy-Cramer et al ([@R38]), 2016   NSCLC                                 CT             40           Yes         830        FO, SM, TA   CCC                               Reproducibility

  Leijenaar et al ([@R39]), 2013         NSCLC                                 PET            34           No          108        FO, SM, TA   ICC                               Repeatability

  Mackin et al ([@R40]), 2015            NSCLC                                 CT             20           No          10         FO, TA       Mean standard deviation           Reproducibility

  Oliver et al ([@R41]), 2015            NSCLC                                 PET            23           No          56         FO, SM, TA   Average percentage difference     Reproducibility

  Parmar et al ([@R42]), 2014            NSCLC                                 PET            20           Yes         56         FO, SM, TA   ICC                               Reproducibility

  Van Velden et al ([@R43]), 2016        NSCLC                                 PET            11           No          105        FO, SM, TA   ICC                               Reproducibility

  Yan et al ([@R44]), 2015               NSCLC                                 PET            17           No          64         FO, TA       Mean standard deviation           Reproducibility

  Yip et al ([@R45]), 2014               NSCLC                                 PET            26           No          4          TA           Relative difference               Reproducibility

  Zhao et al ([@R46]), 2016              NSCLC                                 CT             32           No          89         FO, SM, TA   CCC                               Repeatability, reproducibility

  Grootjans et al ([@R47]), 2016         Lung cancer                           PET            60           No          4          TA           Mean standard deviation           Reproducibility

  Koo et al ([@R48]), 2017               Lung cancer                           CT             194          No          9          FO, SM       ICC                               Reproducibility

  Lasnon et al ([@R49]), 2016            Lung cancer                           PET            60           No          5          TA           Mean standard deviation           Reproducibility

  Bagher-Ebadian et al ([@R50]), 2017    Oropharyngeal cancer                  CT, CBCT       18           No          165        FO, TA       Mean absolute percentage change   Reproducibility

  Bogowicz et al ([@R51]), 2016          Oropharyngeal cancer                  CT             22           No          315        FO, TA       ICC                               Reproducibility

  Lu et al ([@R52]), 2016                Oropharyngeal cancer                  PET            40           No          88         FO, SM, TA   ICC                               Reproducibility

  Doumou et al ([@R53]), 2015            Esophageal cancer                     PET            64           No          57         TA           Spearman correlation              Reproducibility

  Hatt et al ([@R54]), 2013              Esophageal cancer                     PET            50           No          10         FO, TA       Mean standard deviation           Reproducibility

  Tixier et al ([@R55]), 2012            Esophageal cancer                     PET            16           No          25         FO, TA       ICC                               Reproducibility

  Hu et al ([@R56]), 2016                Rectal cancer                         CT             40           No          775        TA           ICC                               Repeatability

  Orlhac et al ([@R19]), 2014            Rectal cancer, NSCLC, breast cancer   PET            28, 24, 54   No          41         FO, TA       Spearman correlation              Reproducibility

  Van Timmeren et al ([@R57]), 2016      Rectal cancer, lung cancer            CT             40, 40       No          542        FO, SM, TA   CCC                               Repeatability

  Guan et al ([@R58]), 2016              Cervical cancer                       MR             51           No          8          FO, TA       ICC                               Reproducibility

  Galavis et al ([@R59]), 2010           Various solid tumors                  PET            20           No          50         FO, TA       Average percentage difference     Reproducibility

  Hatt et al ([@R60]), 2015              Various solid tumors                  PET            555          No                     TA           Spearman correlation              Reproducibility
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Abbreviations:* CBCT = cone beam computed tomography; CCC = concordance correlation coefficient; CT = computed tomography; FO = first order; ICC = intraclass correlation coefficient; MR = magnetic resonance; NSCLC = non-small cell lung cancer; PET = positron emission to-mography; SM = shape metric; TA = textural analysis.

###### 

Summary of pure phantom studies included in analysis

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                               Phantom used                                    Modality\      Primary set\   Total no.\    Class of\    Statistical\               Type of study
                                                                                          investigated   made public    of features   features     analysis                   
  --------------------------------------- ----------------------------------------------- -------------- -------------- ------------- ------------ -------------------------- -----------------
  Buch et al ([@R61]), 2017               Nonanatomic in-house phantom                    CT             No             42            FO, TA       Student t test             Reproducibility

  Forgacs et al ([@R62]), 2016            NEMA-IQ phantom                                 PET            No             26            TA           Coefficient of variation   Reproducibility

  Kim et al ([@R63]), 2015                AAPM CT performance phantom model 76-410-4130   CT             No               5           TA           Unclear                    Reproducibility

  Lo et al ([@R64]), 2016                 Water phantom                                   CT             No             26            FO, TA       Mean standard deviation    Reproducibility

  Shafiq-Ul-Hassan et al ([@R65]), 2017   Credence Cartridge Radiomics phantom            CT             No                213        FO, SM, TA   Coefficient of variation   Reproducibility

  Zhao et al ([@R66]), 2014               Anthropomorphic thorax phantom                  CT             No             15            SM, TA       Multilinear regression     Reproducibility
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Abbreviations:* AAPM = American Association of Physicists in Medicine; CT = computed tomography; FO = first order; NEMA-IQ = National Electrical Manufacturers Association-Image Quality; PET = positron emission tomography; SM = shape metric; TA = textural analysis.

###### 

Quality of reporting analysis for human studies

  ------------------------------------------------------------------------------------------------------------------------------------
  Reference                              Cohort\    Software\   Image\                  Preprocessing\   Segmentation\   Metric\
                                         details\   details\    acquisition settings\   details\         details\        thresholds\
                                         stated     stated      provided                provided         provided        stated
  -------------------------------------- ---------- ----------- ----------------------- ---------------- --------------- -------------
  Aerts et al ([@R4]), 2014              Yes        Yes         Yes                     No               Yes             No

  Bagher-Ebadian et al ([@R50]), 2017    Yes        Yes         Yes                     Yes              Yes             No

  Balagurunathan et al ([@R28]), 2014    Yes        Yes         Yes                     Yes              Yes             Yes

  Bogowicz et al ([@R51]), 2016          Yes        Yes         Yes                     Yes              Yes             Yes

  Cheng et al ([@R29]), 2016             Yes        Yes         Yes                     No               Yes             No

  Coroller et al ([@R30]), 2016          Yes        No          Yes                     Yes              Yes             Yes

  Desseroit et al ([@R31]), 2017         Yes        No          No                      Yes              Yes             No

  Desseroit et al ([@R32]), 2016         Yes        No          Yes                     No               No              No

  Doumou et al ([@R53]), 2015            Yes        Yes         Yes                     Yes              Yes             Yes

  Fave et al ([@R33]), 2015              Yes        Yes         Yes                     Yes              Yes             Yes

  Fave et al ([@R34]), 2015              Yes        Yes         Yes                     Yes              Yes             No

  Fave et al ([@R35]), 2016              Yes        Yes         Yes                     Yes              No              Yes

  Fried et al ([@R36]), 2014             Yes        Yes         Yes                     Yes              Yes             Yes

  Galavis et al ([@R59]), 2010           No         Yes         Yes                     Yes              Yes             Yes

  Guan et al ([@R58]), 2016              Yes        No          Yes                     Yes              Yes             Yes

  Grootjans et al ([@R47]), 2016         Yes        No          Yes                     Yes              Yes             No

  Hatt et al ([@R54]), 2013              Yes        No          Yes                     Yes              Yes             No

  Hatt et al ([@R60]), 2015              Yes        No          Yes                     Yes              Yes             No

  Hu et al ([@R56]), 2016                Yes        Yes         Yes                     Yes              Yes             Yes

  Huynh et al ([@R37]), 2017             Yes        Yes         Yes                     No               No              Yes

  Kalpathy-Cramer et al ([@R38]), 2016   Yes        Yes         Yes                     No               Yes             Yes

  Koo et al ([@R48]), 2017               Yes        No          Yes                     Yes              Yes             No

  Lasnon et al ([@R49]), 2016            Yes        No          Yes                     Yes              Yes             No

  Leijenaar et al ([@R39]), 2013         Yes        Yes         Yes                     No               Yes             Yes

  Lu et al ([@R52]), 2016                Yes        Yes         Yes                     Yes              Yes             Yes

  Mackin et al ([@R40]), 2015            Yes        Yes         Yes                     Yes              No              No

  Oliver et al ([@R41]), 2015            Yes        No          Yes                     No               Yes             Yes

  Orlhac et al ([@R19]), 2014            Yes        No          Yes                     Yes              Yes             No

  Parmar et al ([@R42]), 2014            Yes        Yes         Yes                     Yes              Yes             Yes

  Tixier et al ([@R55]), 2012            Yes        No          Yes                     Yes              Yes             No

  Van Velden et al ([@R43]), 2016        Yes        No          Yes                     Yes              Yes             Yes

  Van Timmeren et al ([@R57]), 2016      Yes        No          Yes                     Yes              No              Yes

  Yan et al ([@R44]), 2015               Yes        No          Yes                     Yes              Yes             Yes

  Yip et al ([@R45]), 2014               Yes        Yes         Yes                     Yes              No              No

  Zhao et al ([@R46]), 2016              Yes        No          Yes                     No               Yes             Yes
  ------------------------------------------------------------------------------------------------------------------------------------

Each cell indicates whether it was possible to evince sufficient information from the text to re-create the experiment (yes) or not (no).

###### 

Quality of reporting analysis for phantom studies

  ----------------------------------------------------------------------------------------------------------------------------------
  Reference                               Phantom\   Software\   Image acquisition\   Preprocessing\   Segmentation\   Metric\
                                          details\   details\    settings\            details\         details\        thresholds\
                                          stated     stated      provided             provided         provided        stated
  --------------------------------------- ---------- ----------- -------------------- ---------------- --------------- -------------
  Buch et al ([@R61]), 2017               Yes        Yes         Yes                  Yes              Yes             No

  Forgacs et al ([@R62]), 2016            Yes        No          Yes                  No               No              Yes

  Kim et al ([@R63]), 2015                Yes        Yes         Yes                  Yes              Yes             No

  Lo et al ([@R64]), 2016                 Yes        No          Yes                  Yes              Yes             No

  Shafiq-ul-Hassan et al ([@R65]), 2017   Yes        No          Yes                  Yes              Yes             No

  Zhao et al ([@R66]), 2014               Yes        No          Yes                  Yes              Yes             No
  ----------------------------------------------------------------------------------------------------------------------------------

Each cell indicates whether it was possible to evince sufficient information from the text to re-create the experiment (yes) or not (no).
